1-[(5S,8S,11S,21R)-5,8-bis(4-aminobutyl)-11-benzyl-4,7,10,14,17,20-hexaoxo-1-oxa-3,6,9,13,16,19-hexazacyclotricos-21-yl]guanidine

ID: ALA5192996

Chembl Id: CHEMBL5192996

PubChem CID: 168286143

Max Phase: Preclinical

Molecular Formula: C32H53N11O7

Molecular Weight: 703.85

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)N[C@@H]1CCOCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2ccccc2)CNC(=O)CNC(=O)CNC1=O

Standard InChI:  InChI=1S/C32H53N11O7/c33-13-6-4-10-23-30(48)40-20-50-15-12-25(43-32(35)36)29(47)39-19-27(45)38-18-26(44)37-17-22(16-21-8-2-1-3-9-21)28(46)41-24(31(49)42-23)11-5-7-14-34/h1-3,8-9,22-25H,4-7,10-20,33-34H2,(H,37,44)(H,38,45)(H,39,47)(H,40,48)(H,41,46)(H,42,49)(H4,35,36,43)/t22-,23-,24-,25+/m0/s1

Standard InChI Key:  INHPREGOZLFYLU-OJJQZRKESA-N

Alternative Forms

  1. Parent:

    ALA5192996

    ---

Associated Targets(non-human)

F2 Thrombin (1630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypsin (394 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 703.85Molecular Weight (Monoisotopic): 703.4129AlogP: -3.23#Rotatable Bonds: 11
Polar Surface Area: 297.77Molecular Species: BASEHBA: 10HBD: 11
#RO5 Violations: 2HBA (Lipinski): 18HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.69CX Basic pKa: 11.02CX LogP: -4.70CX LogD: -11.79
Aromatic Rings: 1Heavy Atoms: 50QED Weighted: 0.06Np Likeness Score: 0.57

References

1. Huber S, Braun NJ, Schmacke LC, Quek JP, Murra R, Bender D, Hildt E, Luo D, Heine A, Steinmetzer T..  (2022)  Structure-Based Optimization and Characterization of Macrocyclic Zika Virus NS2B-NS3 Protease Inhibitors.,  65  (9.0): [PMID:35475620] [10.1021/acs.jmedchem.1c01860]

Source